Healthcare provider profile · identity verified

Mark Biedrzycki

Family Practice · PITTSBURGH, PA · NPI 1194797233

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	572	184
Amlodipine Besylate	Amlodipine Besylate	417	153
Levothyroxine Sodium	Levothyroxine Sodium	371	111
Metoprolol Succinate	Metoprolol Succinate	271	82
Lisinopril	Lisinopril	270	95
Gabapentin	Gabapentin	255	87
Sertraline Hcl	Sertraline Hcl	246	71
Losartan Potassium	Losartan Potassium	244	74
Eliquis	Apixaban	212	45
Pantoprazole Sodium	Pantoprazole Sodium	211	75
Omeprazole	Omeprazole	203	64
Rosuvastatin Calcium	Rosuvastatin Calcium	196	69
Metformin Hcl Er	Metformin Hcl	180	71
Tamsulosin Hcl	Tamsulosin Hcl	166	54
Famotidine	Famotidine	163	65
Fluticasone Propionate	Fluticasone Propionate	161	65
Jardiance	Empagliflozin	131	34
Fluoxetine Hcl	Fluoxetine Hcl	127	34
Duloxetine Hcl	Duloxetine Hcl	116	32
Glipizide Er	Glipizide	105	33
Alendronate Sodium	Alendronate Sodium	104	32
Prednisone	Prednisone	101	80
Bupropion Xl	Bupropion Hcl	98	25
Albuterol Sulfate Hfa	Albuterol Sulfate	95	41
Allopurinol	Allopurinol	95	32
Finasteride	Finasteride	95	28
Tramadol Hcl	Tramadol Hcl	95	27
Simvastatin	Simvastatin	92	30
Metformin Hcl	Metformin Hcl	90	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	88	28
Synthroid	Levothyroxine Sodium	84	26
Ozempic	Semaglutide	83	20
Propranolol Hcl Er	Propranolol Hcl	82	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	82	21
Hydrochlorothiazide	Hydrochlorothiazide	76	30
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	25
Potassium Chloride	Potassium Chloride	69	23
Pregabalin	Pregabalin	69	suppressed
Valsartan	Valsartan	69	23
Carvedilol	Carvedilol	67	22
Pravastatin Sodium	Pravastatin Sodium	67	24
Atenolol	Atenolol	64	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	29
Furosemide	Furosemide	63	21
Montelukast Sodium	Montelukast Sodium	63	20
Quetiapine Fumarate	Quetiapine Fumarate	63	16
Escitalopram Oxalate	Escitalopram Oxalate	61	18
Trazodone Hcl	Trazodone Hcl	61	25
Lorazepam	Lorazepam	59	30
Bisoprolol Fumarate	Bisoprolol Fumarate	58	25
Metoprolol Tartrate	Metoprolol Tartrate	57	22
Trulicity	Dulaglutide	56	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	22
Xarelto	Rivaroxaban	51	13
Clopidogrel	Clopidogrel Bisulfate	50	17
Bupropion Hcl Sr	Bupropion Hcl	49	11
Zolpidem Tartrate	Zolpidem Tartrate	48	18
Warfarin Sodium	Warfarin Sodium	46	18
Doxycycline Monohydrate	Doxycycline Monohydrate	45	41
Levetiracetam	Levetiracetam	45	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	45	21
Spironolactone	Spironolactone	43	18
Meloxicam	Meloxicam	41	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	16
Citalopram Hbr	Citalopram Hydrobromide	39	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	16
Hydralazine Hcl	Hydralazine Hcl	39	11
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Celecoxib	Celecoxib	38	14
Doxazosin Mesylate	Doxazosin Mesylate	37	11
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	36	suppressed
Cephalexin	Cephalexin	35	29
Chlorthalidone	Chlorthalidone	35	12
Donepezil Hcl	Donepezil Hcl	35	11
Mirtazapine	Mirtazapine	33	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	33	32
Aripiprazole	Aripiprazole	32	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	27
Meclizine Hcl	Meclizine Hcl	29	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	12
Clonazepam	Clonazepam	28	suppressed
Ketoconazole	Ketoconazole	28	12
Ondansetron Hcl	Ondansetron Hcl	27	18
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	11
Azithromycin	Azithromycin	26	26
Amoxicillin	Amoxicillin	24	20
Lansoprazole	Lansoprazole	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	12
Hydroxyzine Hcl	Hydroxyzine Hcl	22	11
Bumetanide	Bumetanide	21	suppressed
Colchicine	Colchicine	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	14
Topiramate	Topiramate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	15
Digoxin	Digoxin	19	suppressed
Lactulose	Lactulose	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Baclofen	Baclofen	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Creon	Lipase/Protease/Amylase	16	suppressed
Diazepam	Diazepam	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Xifaxan	Rifaximin	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Glipizide	Glipizide	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Nyamyc	Nystatin	13	suppressed
Prevalite	Cholestyramine	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Nystatin	Nystatin	11	suppressed
Nystop	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error